Veravas

In the Know: Healthcare News for September 28, 2020

Bright Health Inc. Announces $500 Million Series E Funding Including Significant Investments by Tiger Global Management, T. Rowe Price Associates, Blackstone, NEA and Bessemer Venture Partners Bind Launches Into the Fully-insured Market Spineology Gets FDA De Novo Grant of Minimally Invasive OptiMesh Expandable Interbody Fusion System Medtronic gains breakthrough nod for VAD driveline Fast Company […]

Veravas Announces Novel Rapid Antigen Assay for SARS-CoV-2 Detection in Saliva

Saliva-based, high-throughput rapid antigen assay reportedly detects SARS-CoV-2 with similar sensitivity and specificity as PCR in only 10 minutes. CHARLESTON, S.C. (PRWEB) SEPTEMBER 24, 2020 – Veravas, Inc. an early-stage biotechnology company, has announced the development of its VeraTest™ SARS-CoV-2 Rapid Antigen Assay, based on their patent-pending VeraPrep™ technology and a proprietary novel antibody fragment with […]

Veravas and MIP Diagnostics Announce International Agreement for Improved Diagnostics

CHARLESTON, S.C. and OAKDALE, Minn., March, 13 2020, – Veravas, Inc., an emerging diagnostic company focusing on sample preparation products and new diagnostic tests and MIP Diagnostics Ltd., the Molecularly Imprinted Polymers (MIPs) specialist based in Sharnbrook, United Kingdom, announced today that they have entered into a mutually beneficial agreement for the development, license, and […]

Veravas and Tymora Collaborate on Early Detection Alzheimer’s Testing

CHARLESTON, S.C. and OAKDALE, Minn., January, 13 2020, – Veravas, Inc. and Tymora Analytical Operations, LLC announced today that they have entered into a strategic alliance to explore the integration of their respective technologies. Veravas is an emerging diagnostic company focused on proprietary sample preparation products and new diagnostic tests. Tymora’s focus is on providing […]

True Diagnostics and Veravas, Inc. Announce Strategic Alliance in the Commercialization of VeraTest Biotin

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ — True Diagnostics, Inc. (True), a leading company for Point of Care (POC) answers, and Veravas, an emerging diagnostic company focusing on proprietary sample preparation products and new diagnostic tests, announced today their Strategic Alliance in the commercialization of VeraTest Biotin, a portable and easy-to-use digital qualitative test that can rapidly screen […]

In the Know: Healthcare News for August 12, 2019

Veritas Capital-backed Guidehouse to Acquire Navigant Consulting, Inc. for $1.1 Billion Mortenson plans second, bigger Discovery Square building in Rochester University of Minnesota achieves transplant in monkeys without long-term immune-fighting drugs Blue Cross and Blue Shield of Minnesota Initiative Aims to Catalyze Creative Solutions to Health Inequities Abbott ramping up FreeStyle Libre production following bountiful […]

In the Know: Medical Alley News for July 1, 2019

UnitedHealth Agrees to Buy Payments Firm Equian for $3.2 Billion Blue Cross and Blue Shield of Minnesota and North Memorial Health Join Forces to Transform Healthcare in Minnesota Sansoro Health and Datica Announce Merger Optum exec will become new UnitedHealthcare CEO Mayo Clinic receives $5 million gift to establish Center for Women’s Health Minnesota Cup […]

Veravas Announces Appointments of Chief Scientific Officer and Chief Clinical Officer

Company secured more than $2 million in seed funding to support advancement and commercialization of sample prep technology and novel diagnostic tests CHARLESTON, S.C. & OAKDALE, Minn.–(BUSINESS WIRE)–Veravas, Inc., an emerging diagnostic company, appointed Joshua Soldo as the chief scientific officer and Carmen Wiley, Ph.D., as chief clinical officer. Mr. Soldo and Dr. Wiley have […]

In The Know: News from Medical Alley for June 24, 2019

UnitedHealth to buy health-payment business Equian for $3.2B, WSJ says Dutch health care giant to move into One Discovery Square Murata Vios, Inc. Announces FDA Clearance for Second Generation Wireless Monitoring Platform Zoll acquires TherOx Colorado’s Ski Towns Could Fix the High Cost of American Health Care FTC puts limit on $4.3 billion clinic deal […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER